⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
LLY News
Eli Lilly & Co.
Ozempatch: Do Herbal Weight Loss Patches Actually Work? 2026 Consumer Analysis as GLP-1 Patch Ads Surge During Resolution Season
globenewswire.com
NVO
LLY
Best Weight Loss Pills for 2026? FDA Approves First Oral GLP-1 as Patients Evaluate Wegovy, Zepbound, and Telehealth Access Pathways
globenewswire.com
NVO
LLY
Capital Square Launches New Active Living DST Offering in Richmond's Short Pump Submarket
prnewswire.com
LLY
Best Peptides for Weight Loss 2026: Industry Analysis Examines Compounded GLP-1 Telehealth Access and Pricing Transparency
globenewswire.com
NVO
LLY
GLP-1 Agonists (Ozempic, Wegovy, Mounjaro) Market - Global Forecast to 2033: Growing Shift of Weekly Injectables Toward Orals and Multi-Agonists - ResearchAndMarkets.com
businesswire.com
LLY
NVO
ABL Bio Receives Upfront Payment for License, Research and Collaboration Agreement for Grabody Platform and Equity Investment from Lilly USA - English USA - English APAC - English
prnewswire.com
LLY
Caliway's Fat Reduction Drug Candidate CBL-514 Completes U.S. FDA IND Submission for Phase 2 Clinical Study in Weight Management, Expanding Development Combined with GLP-1RA-Based Weight-Loss Therapies
prnewswire.com
LLY
Obesity Medicine Association Releases Position Statement: A New Era for Medicare & Medicaid Obesity Medication Coverage Ready to Announce with Confidence?
newsfilecorp.com
LLY
NVO
GLP-1 Agonists (Ozempic, Wegovy, Mounjaro) Market - Global Forecast to 2033: With the Semaglutide Patent Expiring in 2026 Onwards, the Biosimilars Market is Expected to Grow Significantly
globenewswire.com
LLY
FNB Harvest annonce Distributions réinvesties annuelles estimées révisées pour les FNB Harvest d'actions à revenu élevé pour 2025
businesswire.com
LLY
AMZN
MSFT
NVDA
COIN
PLTR
TSLA
META
AMD
AVGO
COST
GOOGL
NFLX
AAPL
SOFI